Basel Medical Group Ltd (Nasdaq: BMGL) back in compliance with Nasdaq bid rule
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Basel Medical Group Ltd reports that Nasdaq has notified the company it has regained compliance with Nasdaq’s minimum bid price rule. The ordinary shares closed at $1.00 per share or greater for 10 consecutive business days from June 23, 2026 to July 7, 2026, satisfying Nasdaq Listing Rule 5550(a)(2) after a prior deficiency notice issued on January 22, 2026.
The company continues to operate a network of medical clinics in Singapore focused on orthopedic, trauma, neurosurgical and general medical services, serving corporate and individual clients across multiple locations.
Positive
- Regained Nasdaq listing compliance by meeting the minimum $1.00 bid price for 10 consecutive business days, removing an immediate risk of delisting.
Negative
- None.
Insights
Nasdaq bid-price compliance removes an immediate listing risk.
Basel Medical Group has restored compliance with Nasdaq’s minimum bid price requirement after its shares closed at or above $1.00 for 10 consecutive business days from June 23, 2026 to July 7, 2026. This resolves a deficiency first cited on January 22, 2026, when the stock had traded below $1.00 for 30 straight business days.
Regaining compliance reduces the near-term risk of delisting from the Nasdaq Capital Market, which can affect liquidity and investor access. Future compliance will still depend on maintaining the bid price at or above the required threshold under Listing Rule 5550(a)(2).
Key Figures
Minimum bid price threshold: $1.00 per share
Non-compliance notice date: January 22, 2026
Compliance measurement window: 10 consecutive business days
+2 more
5 metrics
Minimum bid price threshold
$1.00 per share
Required under Nasdaq Listing Rule 5550(a)(2) for continued listing
Non-compliance notice date
January 22, 2026
Date Nasdaq notified BMGL of failure to maintain $1.00 minimum bid price over 30 days
Compliance measurement window
10 consecutive business days
From June 23, 2026 to July 7, 2026 with closing bid at or above $1.00
Prior deficiency window
30 consecutive business days
Period over which shares traded below $1.00 before Nasdaq’s January 22, 2026 notice
Media contact phone
+65 6291 9188
Basel Medical Group Ltd media contact number in Singapore
Key Terms
minimum bid price rule, Listing Rule 5550(a)(2), foreign private issuer, forward-looking statements
4 terms
minimum bid price rule regulatory
"it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq minimum bid price rule"
A minimum bid price rule is a stock market requirement that a listed company's share must trade above a set minimum price over a specified period to remain listed on an exchange. It matters to investors because falling below that threshold can trigger warnings, potential delisting, and reduced liquidity—similar to a student needing a passing grade to stay enrolled—making the shares harder to buy, sell, or value accurately.
Listing Rule 5550(a)(2) regulatory
"Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2)."
Listing Rule 5550(a)(2) is a Nasdaq listing standard that sets a minimum share-price requirement for securities to be listed or to remain listed on the Nasdaq Capital Market. It matters to investors because falling below that minimum can trigger delisting reviews or increased volatility, much like a safety bar on a ride — if a stock can’t meet the height requirement, it risks being removed from the exchange, which can reduce liquidity and access for buyers and sellers.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
forward-looking statements financial
"Certain statements in this announcement are forward-looking statements, which involve known and unknown risks"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What did Basel Medical Group Ltd (BMGL) announce in this Form 6-K?
Basel Medical Group Ltd announced that Nasdaq confirmed the company has regained compliance with the Nasdaq minimum bid price rule for continued listing.
How did BMGL regain compliance with Nasdaq’s minimum bid price rule?
BMGL regained compliance after its ordinary shares had a closing bid price of $1.00 or greater for 10 consecutive business days from June 23, 2026 to July 7, 2026.
When was Basel Medical Group Ltd initially notified of non-compliance by Nasdaq?
On January 22, 2026, Nasdaq notified Basel Medical Group Ltd that its ordinary shares had traded below a $1.00 minimum bid price for 30 consecutive business days.
Which Nasdaq listing rule did BMGL return to compliance with?
Basel Medical Group Ltd returned to compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for continued listing.
What type of services does Basel Medical Group Ltd (BMGL) provide?
Basel Medical Group Ltd provides orthopedic and trauma services, sports medicine, neurosurgical treatments, executive health screening, occupational medicine, rehabilitation, mental and women’s health, and general medical services in Singapore.
Where are Basel Medical Group Ltd’s clinics located in Singapore?
Basel Medical Group Ltd operates clinics at Suntec City Mall, Macpherson Road, Toa Payoh, Margaret Drive, Tampines, Gateway East and Gleneagles Medical Centre in Singapore.